By vgreene, 29 March, 2021 Extended anticoag may be considered if recurrent CVT VTE after CVT or 1st CVT w severe thrombophilia homozygous prothrombin G20210A mutation homozygous factor V Leiden mutation protein C or S deficiencies antithrombin deficiency antiphospholipid syndrome
By vgreene, 29 March, 2021 Initiate anticoag w UFH or LMWH transition to oral anticoagulant when stable
By vgreene, 29 March, 2021 Consider delaying anticoagulation for pts at high risk of hemorrhagic complications
